Advik Laboratories is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company deals in a wide range of pharmaceuticals formulations like Tablets, Capsules and Dry Syrups, etc.Product Portfolio: a) WHO - GMP Certified Generic Products: Antibacterial Antiallergics Antifungals Analgesic Antipyretic Anti-inflammatory Anthelminthic Antihypertensive Antimalarial Antituberculotic…
MPS Pharmaa Limited has published a notice regarding its 32nd Annual General Meeting (AGM), book closure, and remote e-voting information in newspapers. This disclosure ensures shareholders are informed about important corporate events.
MPS Pharmaa Limited is facilitating access to its Annual Report for FY 2025-26 by providing shareholders with a web link and QR code. Shareholders are also urged to update their PAN, KYC, and bank details with the company's Registrar and Transfer Agent to ensure continued access to services and grievance...
MPS Pharmaa Limited's board met to finalize plans for its 32nd Annual General Meeting (AGM) on September 29. Shareholders will vote on key proposals, including the appointment of Ms. Anchal Goyal as an Independent Director for a five-year term, and the re-appointment of M/s. Nemani Garg Agarwal & Co. as...
MPS Pharmaa Limited's board has announced key decisions from its recent meeting. The board approved the 32nd Annual General Meeting (AGM) and its documentation for the financial year 2025-2026. The company set book closure and e-voting periods, appointing NSDL and M/s. Kundan Agrawal & Associates for the voting process. For...
MPS Pharmaa has announced its financial results for the quarter ended June 30. The company reported revenue from operations of ₹1.35 Cr, an increase from ₹1.26 Cr in the same quarter last year. Net loss for the period improved significantly to ₹0.06 Cr, compared to a net loss of ₹0.13...
